Showing results (2031-2040 of 2,488) with videos related to

Sort By:
Pageof 249
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate CancerSean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
JCI Insight|February 20, 2024
Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancerQiang Zhang, Long Jiang, Weiwei Wang, et al.
Synapse (New York, N.Y.)|April 2, 2005
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracersTerence G Hamill, Stephen Krause, Christine Ryan, et al.
Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria® Evaluation of Nipple Discharge, Su-Ju Lee, Sunita Trikha, et al.
Cell Research|August 31, 2011
Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotencyR David Hawkins, Gary C Hon, Chuhu Yang, et al.
Neuro-Oncology|April 10, 2025
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Plos Medicine|February 15, 2008
A collaborative epidemiological investigation into the criminal fake artesunate trade in South East AsiaPaul N Newton, Facundo M Fernández, Aline Plançon, et al.
Data in Brief|June 23, 2020
Data highlighting phenotypic diversity of urine-associated Escherichia coli isolatesAllison R Eberly, Connor J Beebout, Ching Man Carmen Tong, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2025
Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care SystemSean R Miller, Rachel Tucker Gonzalez, William C Jackson, et al.
Pageof 249